Literature DB >> 11065012

Major depression and cancer: the 13-year follow-up of the Baltimore epidemiologic catchment area sample (United States).

J J Gallo1, H K Armenian, D E Ford, W W Eaton, A S Khachaturian.   

Abstract

OBJECTIVE: The relationship between depression and development of cancer is not well understood, with some studies finding a significant but small increase in risk for cancer among persons with depression. No studies have employed standardized interviews keyed to the diagnostic criteria for Major Depression. Our objective was to evaluate the relationship between Major Depression at baseline and new onset of cancer at follow-up.
METHOD: The study was based on a population-based 13-year follow-up survey of community-dwelling adults living in East Baltimore in 1981. After excluding 372 persons with a history of cancer or those whom reported their health as poor at the baseline interview, 3109 adults remained. Information on baseline depression status and cancer at follow-up was available for 2017 persons. A diagnosis of cancer was ascertained at follow-up through interview of survivors and from death certificates.
RESULTS: There were 203 new cases of cancer among 2017 persons at risk. Neither Major Depression (relative risk (RR) = 1.0, 95% confidence interval (CI) 0.5-2.1) nor dysphoric episode (RR = 1.3, 95% CI 0.9-1.9) were significantly associated with increased risk of cancer at follow-up. However, among women with Major Depression, the risk of breast cancer was increased (adjusted RR = 3.8, 95% CI 1.0-14.2).
CONCLUSIONS: We found no overall association of depression with cancer. However, among women, Major Depression (but not dysphoric episode alone) was associated with the onset of breast cancer.

Entities:  

Mesh:

Year:  2000        PMID: 11065012     DOI: 10.1023/a:1008987409499

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  21 in total

1.  Depression and cancer risk: 24 years of follow-up of the Baltimore Epidemiologic Catchment Area sample.

Authors:  Alden L Gross; Joseph J Gallo; William W Eaton
Journal:  Cancer Causes Control       Date:  2009-11-03       Impact factor: 2.506

Review 2.  In the shadow of academic medical centers: a systematic review of urban health research in Baltimore City.

Authors:  Nadra C Tyus; M Christopher Gibbons; Karen A Robinson; Claire Twose; Bernard Guyer
Journal:  J Community Health       Date:  2010-08

Review 3.  [Comorbid depressive and anxiety disorders in patients with cancer].

Authors:  H-P Kapfhammer
Journal:  Nervenarzt       Date:  2015-03       Impact factor: 1.214

4.  Depression, Antidepressant Use, and Postmenopausal Breast Cancer Risk.

Authors:  Susan B Brown; Susan E Hankinson; Kathleen F Arcaro; Jing Qian; Katherine W Reeves
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-11-17       Impact factor: 4.254

5.  Colon cancer treatment costs for Medicare and dually eligible beneficiaries.

Authors:  Zhehui Luo; Cathy J Bradley; Bassam A Dahman; Joseph C Gardiner
Journal:  Health Care Financ Rev       Date:  2010

6.  Living with a concealable stigmatized identity: the impact of anticipated stigma, centrality, salience, and cultural stigma on psychological distress and health.

Authors:  Diane M Quinn; Stephenie R Chaudoir
Journal:  J Pers Soc Psychol       Date:  2009-10

7.  Coping competence as predictor and moderator of depression among chronic disease patients.

Authors:  Kerstin E Schroder
Journal:  J Behav Med       Date:  2004-04

8.  Depressed mood and cause-specific mortality: a 40-year general community assessment.

Authors:  Lisa Wyman; Rosa M Crum; David Celentano
Journal:  Ann Epidemiol       Date:  2012-07-24       Impact factor: 3.797

9.  Antidepressant medication use and breast cancer risk.

Authors:  Karen J Wernli; John M Hampton; Amy Trentham-Dietz; Polly A Newcomb
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-04       Impact factor: 2.890

10.  The effects of tricyclic antidepressants on breast cancer risk.

Authors:  C R Sharpe; J-P Collet; E Belzile; J A Hanley; J-F Boivin
Journal:  Br J Cancer       Date:  2002-01-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.